LAVA THERAPEUTICS N.V. revenue breakdown overview

LAVA THERAPEUTICS N.V. revenue for the last year amounted to 6.13 M EUR, the most of which — 6.63 M EUR — came from its highest performing source at the moment, Novel Bispecific Antibodies, the year earlier bringing 19.04 M EUR. The greatest contribution to the revenue figure was made by Netherlands — last year it brought LAVA THERAPEUTICS N.V. 6.63 M EUR, and the year before that — 19.04 M EUR.